All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Functional recovery results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10210262" target="_blank" >RIV/00216208:11110/13:10210262 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064165:_____/13:10210262

  • Result on the web

    <a href="http://dx.doi.org/10.1017/neu.2013.7" target="_blank" >http://dx.doi.org/10.1017/neu.2013.7</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1017/neu.2013.7" target="_blank" >10.1017/neu.2013.7</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Functional recovery results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

  • Original language description

    Objective ConstaTRE is an open-label, randomised, controlled, relapse prevention trial in patients with stable schizophrenia or schizoaffective disorder switched to risperidone long-acting injectable (RLAI) or oral quetiapine, and was designed to test the hypothesis that injectable antipsychotic treatment with risperidone would be more effective than oral therapy with quetiapine. Here we report the functional recovery results from the ConstaTRE trial. Methods Clinically stable adults previously treatedwith oral risperidone, olanzapine, or oral first-generation antipsychotics were randomised to RLAI or quetiapine for 24 months. Functional recovery was assessed using the Social and Occupational Functioning Assessment Scale (SOFAS) and two quality-of-life (QoL) measures [Medical Outcomes Survey Short Form-12 (SF-12) and Schizophrenia Quality-of-Life Scale Revision 4 (SQLS-R4)]. Results A total of 666 patients were randomised and treated with RLAI (n = 329) or quetiapine (n = 337). Relaps

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FL - Psychiatry, sexology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2013

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Acta Neuropsychiatrica [online]

  • ISSN

    1601-5215

  • e-ISSN

  • Volume of the periodical

    25

  • Issue of the periodical within the volume

    5

  • Country of publishing house

    AR - ARGENTINA

  • Number of pages

    10

  • Pages from-to

    297-306

  • UT code for WoS article

    000330359700007

  • EID of the result in the Scopus database